Amyotrophic Lateral Sclerosis Model.

Area of Science:

• Neuroscience
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons.
• Current treatments for ALS are ineffective, with a 2-5 year survival rate post-symptom onset.
• While most ALS cases are sporadic, 10% are familial, linked to genetic variants.

Purpose of the Study:

• To review the roles of three key ALS-associated genes: TAR DNA-binding protein (TDP-43), fused in sarcoma/translocated in liposarcoma (FUS/TLS), and chromosome 9 open reading frame 72 (C9orf72).
• To highlight the utility of Drosophila melanogaster models in understanding ALS pathogenesis.
• To identify potential targets for disease-modifying therapies.

Main Methods:

• Review of existing literature on ALS genetics and molecular mechanisms.
• Focus on studies utilizing Drosophila melanogaster as a model organism for ALS gene research.
• Analysis of pathogenic variants in TDP-43, FUS/TLS, and C9orf72.

Main Results:

• Genetic variants in over 30 loci provide insights into ALS molecular mechanisms.
• Drosophila models offer a platform to study the pathophysiological effects of ALS-associated genes.
• TDP-43, FUS/TLS, and C9orf72 are critical genes implicated in ALS pathogenesis.

Conclusions:

• Understanding the function of ALS-associated genes is crucial for developing effective treatments.
• Drosophila models are valuable tools for dissecting complex neurodegenerative disease mechanisms.
• Targeting specific genes like TDP-43, FUS/TLS, and C9orf72 holds promise for future ALS therapies.